Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML

NCT07511062 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
TP53 Gene Mutation

Interventions

DRUG: Decitabine
DRUG: Venetoclax
DRUG: Axatilimab

Sponsor

Northside Hospital, Inc.

Collaborators

[object Object]